Table 4.
Predictor variable effects on whole-body BIS variables for determining the effect of Acticoat™
| BIS variable | Covariate | Co-efficient | Confidence intervals | p value | |
|---|---|---|---|---|---|
| Lower | Upper | ||||
| R0 (ohms) | Acticoat™ | − 17.42 | − 39.35 | 4.52 | 0.12 |
| % TBSA | − 1.07 | − 2.75 | 0.61 | 0.21 | |
| Acticoat™#% TBSA | − 4.68 | − 5.37 | − 3.98 | < 0.01* | |
| Initial TBF (L) | − 5.71 | − 8.32 | − 3.09 | < 0.01* | |
| Ri (ohms) | Acticoat™ | − 182.22 | − 265.27 | − 99.16 | < 0.01* |
| % TBSA | 6.50 | − 3.45 | 16.46 | 0.20 | |
| Acticoat™#% TBSA | − 17.98 | − 20.61 | − 15.36 | < 0.01* | |
| Initial TBF (L) | − 32.52 | − 48.16 | − 16.87 | < 0.01* | |
| Rinf (ohms) | Acticoat™ | − 23.87 | − 38.57 | − 9.17 | < 0.01* |
| % TBSA | − 0.01 | − 1.33 | 1.32 | 0.99 | |
| Acticoat™#% TBSA | − 3.96 | − 4.42 | − 3.49 | < 0.01* | |
| Initial TBF (L) | − 5.30 | − 7.37 | − 3.23 | < 0.01* | |
| ECF (L) | Acticoat™ | − 36.23 | − 41.91 | − 30.55 | < 0.01* |
| % TBSA | − 0.04 | − 0.31 | 0.23 | 0.76 | |
| Acticoat™#% TBSA | 1.86 | 1.68 | 2.04 | < 0.01* | |
| Initial TBF (L) | 0.93 | 0.53 | 1.33 | < 0.01* | |
| ICF (L) | Acticoat™ | − 31.00 | − 36.07 | − 25.92 | < 0.01* |
| % TBSA | − 0.15 | − 0.36 | 0.07 | 0.18 | |
| Acticoat™#% TBSA | 2.01 | 1.85 | 2.17 | < 0.01* | |
| Initial TBF (L) | 1.08 | 0.77 | 1.40 | < 0.01* | |
| TBF (L) | Acticoat™ | − 67.23 | − 77.13 | − 57.32 | < 0.01* |
| % TBSA | − 0.19 | − 0.63 | 0.25 | 0.40 | |
| Acticoat™#% TBSA | 3.87 | 3.55 | 4.18 | < 0.01* | |
| Initial TBF (L) | 2.02 | 1.36 | 2.67 | < 0.01* | |
Acticoat™ is in reference to an open wound
R0 resistance at zero frequency, Ri intracellular resistance, Rinf resistance at infinite frequency, ECF extracellular fluid, ICF intracellular fluid, TBF total body fluid, TBSA total body surface area, BIS bioimpedance spectroscopy
*p ≤ 0.05
#Interaction term